|1.||Donnellan, John: 1 article (08/2013)|
|2.||Torreggiani, William C: 1 article (08/2013)|
|3.||Ryan, Davinia: 1 article (08/2013)|
|4.||Kok, Hong Kuan: 1 article (08/2013)|
|5.||Jack, C M: 1 article (08/2012)|
|6.||Heatley, F W: 1 article (08/2012)|
|7.||Khan, H O: 1 article (08/2012)|
|8.||Butler-Manuel, P A: 1 article (08/2012)|
|9.||Rajaratnam, S S: 1 article (08/2012)|
|10.||Keast-Butler, O: 1 article (08/2012)|
|1.||Cytidine Monophosphate (CMP)IBA
01/01/1996 - "The aim of the study was to improve the chondromalacia patellae (CMP) diagnosis by MR imaging under defined compression of the retropatellar cartilage, using a specially designed knee compressor. "
12/01/1993 - "The present study proposes a new MRI-specific staging of chondromalacia patellae (CMP) which is based on cartilage thickness decrease and signal intensity behaviour under compression as well as cartilage morphology in the plain image. "
12/01/2003 - "To investigate the effects of isokinetic exercise on pain and functional test scores of recreational athletes with chondromalacia patellae (CMP) and to examine the correlation between isokinetic parameters and functional tests or pain score. "
|2.||Hyaluronic Acid (Hyaluronan)IBA
10/01/2008 - "Evaluation of magnetic resonance signal modification induced by hyaluronic acid therapy in chondromalacia patellae: a preliminary study."
07/01/2000 - "We investigated the effect of intraarticularly applied hyaluronic acid (hyaluronan) on the cartilaginous structure of experimentally induced chondromalacia patellae in dogs. "
07/01/1998 - "We investigated the effects of intraarticularly applied hyaluronic acid on the cartilage-integrity with early-forms of retropatellar cartilage degeneration (chondromalacia patellae) in dogs. "
|3.||Biological Markers (Surrogate Marker)IBA
08/01/2013 - "The purpose of our study was to evaluate the correlation between subcutaneous fat thickness around the knee joint on axial MRIs as a surrogate marker of obesity, with the presence or absence of chondromalacia patellae. "
08/01/2013 - "Subcutaneous knee fat thickness as a surrogate marker of obesity was positively associated with the presence and severity of chondromalacia patellae on MRI."
09/01/1994 - "Intermediate (grade 2 or 3) chondromalacia patellae was detected in two (13%) of 15 facets with T1-weighted and SPGR MR imaging, in three (20%) of 15 facets with proton density-weighted MR imaging, in seven (47%) of 15 facets with T2-weighted MR imaging, in 11 (73%) of 15 facets with CT arthrography, and in 12 (80%) of 15 facets with MR arthrography. "
01/01/1992 - "We correlated findings on axial MR images of the knee with arthroscopic findings to determine MR findings of chondromalacia patellae on T2-weighted and proton density-weighted images. "
09/01/1994 - "All imaging techniques studied had high specificity and accuracy in the detection and grading of chondromalacia patella; however, both MR arthrography and CT arthrography were more sensitive than T1-weighted, proton density-weighted, and SPGR with fat saturation MR imaging for showing intermediate grades of chondromalacia patellae. "
|6.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
|7.||Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
|8.||compound 351 A (351A)IBA
02/01/2000 - "Density of [(125)I]351A binding to stroma was similar to that to blood vessels in rheumatoid arthritis, but less dense than vascular binding in chondromalacia patellae and osteoarthritis. "
02/01/2000 - "Stromal [(125)I]351A binding densities (B(eq)) and the fraction of synovial section area occupied by ACE-immunoreactivity (fractional area) were higher in synovia from patients with rheumatoid arthritis (B(eq) 28 amol/mm(2), fractional area 0.21) than from those with osteoarthritis (B(eq) 9 amol/mm(2), fractional area 0.10) or chondromalacia patellae (B(eq) 9 amol/mm(2), fractional area 0.09)(p < 0.05). "
02/01/2000 - "Sections of synovia from patients with rheumatoid arthritis (n = 7), osteoarthritis (n = 7) or chondromalacia patellae (n = 6) were tested for immunoreactivity for ACE, and for binding of the ACE inhibitor [(125)I]351A. "
|10.||cartilage matrix proteinIBA
|1.||Spinal Fusion (Spondylosyndesis)
08/01/2012 - "To assess the effectiveness of a modified tibial tubercle osteotomy as a treatment for arthroscopically diagnosed chondromalacia patellae. "
05/01/1982 - "Maquet osteotomy for chondromalacia patellae: avoiding the pitfalls."
01/01/1981 - "[Diagnosis and operative treatment of chondromalacia patellae by osteotomy and ventral or ventral and medial transposition of the tuberositas tibiae (Maquet/Bandi-procedure) (author's transl)]."
04/01/1977 - "Coronal patellar osteotomy: preliminary report of its use in chondromalacia patellae."
08/01/2012 - "The modified tibial tubercle osteotomy for anterior knee pain due to chondromalacia patellae in adults: A five-year prospective study."
09/01/1997 - "All patients had failed results after a minimum of 4 months of physical therapy before surgery, and all patients had grade 2 or worse chondromalacia patellae at the time of debridement. "
04/01/2006 - "We compared short-term changes in biomechanical properties of articular cartilage after treatment with monopolar (mRFE) or bipolar RFE (bRFE) or mechanical debridement (MD) on experimentally created grade II chondromalacia patellae. "